Pharmaceutical Technology

MARCH 6, 2023

Whether one refers to such research as “longevity”, “anti-aging” or “extending healthspan”, it is clear this area has evolved massively over the last few years with more scientists now eager to get drugs in this area from bench to bedside. Aging-related pharmaceuticals and research also need to overcome the barrier of sensational and negative press.

FDA 145

FDA Labelling Pharmaceutical Companies Pharmaceutical Companies 145

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. Over the years, they have been repeatedly challenged as anticompetitive.”

Documentation 97

Documentation FDA Hospitals Dosage 97

Pharmaceutical Technology

APRIL 21, 2023

According to the agency’s website, this event aims to prevent the circulation of unused prescription drugs that could potentially harm American citizens. The Centers for Disease Control and Prevention reports that between August 2021 and August 2022, 107,735 US Americans lost their lives to drug poisoning.

Communication 52

Communication FDA 52

Pharmaceutical Technology

DECEMBER 9, 2022

If this act goes through, it will increase access to medicines and treatments, and significantly expand the available market, especially for those in rural areas previously unable to access services such as diagnostics. by 2040 based on statistics from OECD. Brazilian public spending on healthcare, drug pricing reforms and remote medicine.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Communication 98

Pharmaceutical Technology

MAY 4, 2023

Pfizer’s RSV vaccine will soon also face a US regulatory decision with an upcoming Prescription Drug User Fee Act (PDUFA) date later in May. This vaccine specifically prevents RSV-related lower respiratory tract disease (LRTD). These recommendations and the FDA approval were based on positive AReSVi-006 Phase III trial data.

Vaccines 64

Vaccines FDA Communication Immunization 64

Pharmaceutical Technology

JANUARY 5, 2023

For example, while the recently introduced US Inflation Reduction Act is expected to bring drug costs down, it may discourage the pharmaceutical industry from further investments in innovative drugs. To adapt is the only way to thrive. The pharmaceutical sector will need to find new ways to offset regulatory and inflationary pressures.

Vaccines 69

Vaccines Labelling Communication 69

Pharmaceutical Technology

JUNE 21, 2023

The active ingredient in both drugs is empagliflozin, which acts by increasing the excretion of glucose in the urine. The drugs are approved for use along with changes in diet and exercise. This is the first time the FDA has approved an oral diabetes drug for paediatric patients since its approval of metformin in 2000. in the placebo group.

FDA 59

FDA Communication 59

Pharmaceutical Technology

MAY 10, 2023

Vydura is an oral tablet that acts as a calcitonin gene-related peptides (CGRP) receptor antagonist. On May 9, The Scottish Medicines Consortium approved the inclusion of Pfizer and Biohaven’s Vydura (rimegepant) into the Scottish National Health Services (NHS) for the acute treatment of migraines.

Communication 52

Communication 52

Pharmaceutical Technology

APRIL 24, 2023

Tarpeyo is an oral, delayed-release version of budesonide that acts as a glucocorticoid receptor agonist. Everest Medicines launched its immunoglobulin A (IgA) nephropathy drug Tarpeyo (Nefecon) (budesonide) in China’s Hainan Boao Pilot Zone, making it the first therapy available in this disease area.

Communication 52

Communication Immunization Hospitals FDA 52

Pharmaceutical Technology

APRIL 20, 2023

The lawsuit was first filed in 2021 when Amgen accused Dr. Reddy’s Laboratories , Sandoz and Zydus of violating the Hatch-Waxman Act. This court decision gives the company five more years of market exclusivity before generics can enter the market. In 2022, Otezla made up for 9% of Amgen’s total product sales, having sold over $2.2

FDA 52

FDA Communication 52

Pharmaceutical Technology

APRIL 21, 2023

It works by acting as an opioid receptor antagonist. Emergent Biosolutions, maker of the opioid overdose reversing nasal spray Narcan, intends to price the treatment at less than $50 for a kit of two 4mg doses for over-the-counter use (OTC) the company said in a statement. Free Report How is the Biopharmaceutical industry evolving?

Packaging 52

Packaging Communication FDA 52

Pharmaceutical Technology

MARCH 31, 2023

He said, “miRNA 22 acts on three major pathways: lipogenesis and deposition, mitochondria and energy expenditure, and collagen deposition and fibrosis. This year, competition in the obesity therapeutic landscape has ramped up as biotechs aim to follow the success of blockbuster drugs from Novo Nordisk , Eli Lilly and more.

Communication 52

Communication 52

Pharmaceutical Technology

MAY 15, 2023

The FDA will assess the drug’s approval before its Prescription Drug User Fee Act (PDUFA) date on 29 May 2023. The gene therapy consists of a gene coding for micro-dystrophin carried through a recombinant adeno-associated virus vector. If approved, the therapy could become the first FDA-approved gene transfer therapy for the condition.

FDA 52

FDA Hospitals Communication 52

Pharmaceutical Technology

JANUARY 16, 2023

In that context, the United States Inflation Reduction Act is set to garner significant attention this year. Under this act, pharmaceutical companies operating in the US will also have to contend with the imposition of inflationary rebates for Medicare utilization in 2023.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 64

Pharmaceutical Technology

MARCH 30, 2023

Quantifying ethylene glycol and diethylene glycol in Glycerin In January this year, the WHO responded by releasing an urgent call for its almost 200-member states to act to prevent, detect and respond to incidents of substandard and falsified medical products. Most of the children were under the age of 5.

Communication 52

Communication 52

Pharmaceutical Technology

NOVEMBER 30, 2022

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. were overweight but not obese.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

MAY 1, 2023

GSK’s leading competitor, Pfizer also has a pending Prescription Drug User Fee Act ( PDUFA ) date for its RSV vaccine, PF-06928316 or RSVpreF, which is aimed at individuals ages 60 years and above, for May 31. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.

Vaccines 52

Vaccines Nursing Homes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 23, 2023

Using tildacerfont, which also acts as a modulator of ACTH release, Spruce aims to determine if modulating the amount of ACTH regulates the amount of adrenal androgens present in the context of PCOS. While lifestyle modifications play a key role in treating PCOS, the paucity of new treatments signal a need for breakthrough research.

Communication 52

Communication 52

Pharmaceutical Technology

NOVEMBER 30, 2022

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. were overweight but not obese.

Insurance 98

Insurance Labelling Communication FDA 98

Pharmaceutical Technology

JANUARY 16, 2023

In that context, the United States Inflation Reduction Act is set to garner significant attention this year. Under this act, pharmaceutical companies operating in the US will also have to contend with the imposition of inflationary rebates for Medicare utilization in 2023.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 52

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Dosage 52

Dosage Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

DECEMBER 19, 2022

Last week, the US Federal Reserve raised interest rates for the seventh time this year in a continuing bid to stave off worries of a recession. The International Monetary Fund predicts that real gross domestic product (GDP) growth in the US will fall from 1.6% in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Generic Medicine Communication 69

Pharmaceutical Technology

FEBRUARY 28, 2023

1983 was a pivotal year for the rare disease community, with the US Food and Drug Administration’s introduction of the Orphan Drug Act. Around the world, roughly 300 million individuals are living with a rare disease, 70% of which start in childhood. Most rare diseases are debilitating and even life-threatening.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

JUNE 16, 2023

UTD1 is a microtubule stabilising agent, acting as an anti-neoplastic drug. It is currently marketed for breast cancer treatment in China and trialled globally for treating pancreatic, gastric, bile duct, ovarian, prostate and breast cancers, as well as solid tumours. as the secondary endpoints. ORR, 81.0% DCR (disease control rate), 4.37

FDA 52

FDA Chemotherapy Labelling Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 26, 2022

The once cut-throat business landscape is evolving, and business ecosystems are on the rise. Open APIs are facilitating unprecedented collaboration, enabling businesses to pool their resources and expertise to develop better solutions for end users. The opportunities for new innovations and functionalities are enormous. Companies are taking note.

Communication 52

Communication Compounding 52

Pharmaceutical Technology

DECEMBER 21, 2022

The once cut-throat business landscape is evolving, and business ecosystems are on the rise. Open APIs are facilitating unprecedented collaboration, enabling businesses to pool their resources and expertise to develop better solutions for end users. The opportunities for new innovations and functionalities are enormous. Companies are taking note.

Communication 52

Communication Compounding 52

Pharmaceutical Technology

JANUARY 6, 2023

Formulating products that have the proper composition, viscosity, texture, and stability, and can also be shown to be safe and effective, is both a science and an art. Expertise in analytical testing, validation, and quality control are also essential. Simplicity matters. Optimising development and scale-up.

Dosage 52

Dosage Packaging Communication 52